Tilray's Q3 Results Mixed Amid Regulatory Concerns
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy TLRY?
Source: stocktwits
- Rating Upgrade: Roth Capital upgraded Tilray's rating from 'Neutral' to 'Overweight' while maintaining a $10 price target, indicating confidence in the company's international growth despite regulatory uncertainties looming over the industry.
- Earnings Highlights: Tilray reported a 19% year-over-year revenue increase to $206.7 million, surpassing the $201.3 million expectation, while net loss significantly narrowed to $25.2 million, reflecting improvements in business fundamentals.
- Market Reaction: Despite the positive earnings report, TLRY shares fell 1.5% in early Thursday trading, highlighting investor concerns regarding increasing regulatory restrictions on cannabis products in the U.S.
- Analyst Sentiment: While Alliance Global lowered its price target on TLRY to $7, the overall analyst outlook remains cautious, with 7 out of 10 analysts rating the stock as 'Hold', indicating a divergence in views on future growth potential.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TLRY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TLRY
Wall Street analysts forecast TLRY stock price to rise
4 Analyst Rating
1 Buy
3 Hold
0 Sell
Hold
Current: 6.470
Low
8.50
Averages
9.57
High
10.00
Current: 6.470
Low
8.50
Averages
9.57
High
10.00
About TLRY
Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. It operates through four segments: cannabis operations, beverage operations, distribution operations, and the wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The beverage operations, which encompasses the production, marketing and of beverage products. The distribution operations, which encompasses the purchase and resale of pharmaceutical products to customers. The Wellness products, which encompasses wellness and better-for-you foods and beverages. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, Chowie Wowie and others. It supports over 40 brands in over 20 countries, including cannabis offerings, hemp-based foods and craft beverages.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Tilray Reports 73% Net Revenue Growth in Q3, Expands Global Beverage Platform
- International Growth: Tilray's international cannabis business achieved over 70% year-over-year growth in Q3, driving net revenue to $206.7 million, an 11% increase from the previous year, showcasing the company's strong execution and growth potential in global markets.
- Surge in Cannabis Sales: Cannabis flower sales volume doubled year-over-year, resulting in cannabis net revenue of $64.8 million, reflecting robust demand in both Canadian and international markets, further solidifying its market leadership position.
- BrewDog Acquisition: Tilray's acquisition of BrewDog for approximately £40 million marks a significant expansion in the global beverage market, expected to enhance its brand portfolio and distribution capabilities, driving future growth.
- Strong Financial Position: As of the end of Q3, Tilray reported $264.8 million in cash and marketable securities, indicating strong financial flexibility to support strategic investments and growth initiatives moving forward.
See More
Tilray's Q3 Results Mixed Amid Regulatory Concerns
- Rating Upgrade: Roth Capital upgraded Tilray's rating from 'Neutral' to 'Overweight' while maintaining a $10 price target, indicating confidence in the company's international growth despite regulatory uncertainties looming over the industry.
- Earnings Highlights: Tilray reported a 19% year-over-year revenue increase to $206.7 million, surpassing the $201.3 million expectation, while net loss significantly narrowed to $25.2 million, reflecting improvements in business fundamentals.
- Market Reaction: Despite the positive earnings report, TLRY shares fell 1.5% in early Thursday trading, highlighting investor concerns regarding increasing regulatory restrictions on cannabis products in the U.S.
- Analyst Sentiment: While Alliance Global lowered its price target on TLRY to $7, the overall analyst outlook remains cautious, with 7 out of 10 analysts rating the stock as 'Hold', indicating a divergence in views on future growth potential.
See More
Tilray Brands Reports Record Q3 Revenue Driven by International Growth and Strategic Acquisitions
- Record Revenue: Tilray achieved net revenue of $206.7 million in Q3 FY2026, reflecting strong growth in international markets, which is expected to drive further growth in the future.
- International Market Growth: International cannabis sales reached $24.1 million, marking a 73% year-over-year increase, indicating Tilray's successful global positioning, particularly with its distribution network expanding to over 16,000 pharmacies in Germany, enhancing market penetration.
- Strategic Acquisitions and Partnerships: Tilray acquired BrewDog for approximately EUR 40 million, expected to elevate its global craft beverage platform to around $500 million, while also entering a strategic licensing partnership with Carlsberg set to launch in January 2027, further strengthening its beverage business.
- Profitability and Outlook: The company reaffirmed its fiscal 2026 adjusted EBITDA guidance range of $62 million to $72 million, and despite facing price pressures and rising aluminum costs, management remains optimistic about future profitability.
See More
Tilray Brands Reports Record Q3 Revenue of $206.7 Million
- Significant Revenue Growth: Tilray Brands Inc (NASDAQ:TLRY) achieved a record third-quarter revenue of $206.7 million, marking an 11% year-over-year increase, demonstrating strong performance in international markets, particularly with a 73% rise in international cannabis revenue and a 43% growth in Germany, laying a solid foundation for future expansion.
- Cost Savings Impact: The successful completion of Project 420 resulted in $33 million in annualized cost savings, improving the underlying cost structure of the beverage business, which enhances the company's profitability in a highly competitive market.
- Strategic Acquisition Boost: The acquisition of BrewDog positions Tilray as a $1.2 billion global revenue company, significantly enhancing its long-term growth profile, indicating its commitment to expanding in the global beverage market.
- Strong Financial Position: Tilray maintains a robust financial position with $265 million in cash, restricted cash, and marketable securities, providing flexibility for future growth investments, despite facing integration and regulatory challenges in international markets.
See More
Rythm and Green Thumb Amend Licensing Agreement for Long-Term Revenue
- Agreement Revision: Rythm amended its trademark and recipe licensing agreement with Green Thumb, allowing the latter to continue using Rythm's brand portfolio, including incredibles and Beboe, ensuring sustained market competitiveness.
- Fixed Annual Fee: Under the new terms, effective April 1, 2026, Green Thumb will pay Rythm a fixed annual cash fee of $70 million, with annual increases tied to inflation at twice the Consumer Price Index (CPI), providing Rythm with a stable long-term revenue stream.
- Stock Price Surge: Rythm's shares surged nearly 45% on Wednesday, marking the largest intraday gain of 2026 and breaching the 100-day moving average for the first time since December 18, 2025, indicating strong market confidence in its future growth.
- Market Sentiment Shift: Retail sentiment for RYM shifted from 'neutral' to 'extremely bullish', reflecting positive reactions to the new agreement, particularly regarding the anticipated boost in Rythm's gross margins from the royalty fees.
See More
Tilray Reports 19% Revenue Growth in Q3, Driven by International Sales Surge
- Surge in International Sales: Tilray's Q3 revenue climbed 19% to $206.7 million, driven by a remarkable 73% increase in international sales to $64.8 million, demonstrating strong demand in global markets and solidifying its position in the international cannabis sector.
- Significant Loss Reduction: The company's net loss narrowed dramatically from $793.5 million a year ago to $25.2 million, with loss per share improving to $0.24, although it fell short of the consensus estimate of $0.14, reflecting progress in cost control and operational efficiency.
- EBITDA Outlook Reaffirmed: Tilray reaffirmed its FY2026 EBITDA outlook between $62 million and $72 million, indicating confidence in future profitability, despite a 24% decline in beverage revenue to $42.6 million, with management remaining optimistic about international expansion.
- Investor Sentiment Shift: Following the strong earnings report, Tilray's shares jumped 4% on Wednesday, while retail investor sentiment on Stocktwits shifted from 'neutral' to 'extremely bullish', indicating market recognition of the company's growth potential.
See More
Tilray Reports 73% Net Revenue Growth in Q3, Expands Global Beverage Platform
- International Growth: Tilray's international cannabis business achieved over 70% year-over-year growth in Q3, driving net revenue to $206.7 million, an 11% increase from the previous year, showcasing the company's strong execution and growth potential in global markets.
- Surge in Cannabis Sales: Cannabis flower sales volume doubled year-over-year, resulting in cannabis net revenue of $64.8 million, reflecting robust demand in both Canadian and international markets, further solidifying its market leadership position.
- BrewDog Acquisition: Tilray's acquisition of BrewDog for approximately £40 million marks a significant expansion in the global beverage market, expected to enhance its brand portfolio and distribution capabilities, driving future growth.
- Strong Financial Position: As of the end of Q3, Tilray reported $264.8 million in cash and marketable securities, indicating strong financial flexibility to support strategic investments and growth initiatives moving forward.
See More
Tilray's Q3 Results Mixed Amid Regulatory Concerns
- Rating Upgrade: Roth Capital upgraded Tilray's rating from 'Neutral' to 'Overweight' while maintaining a $10 price target, indicating confidence in the company's international growth despite regulatory uncertainties looming over the industry.
- Earnings Highlights: Tilray reported a 19% year-over-year revenue increase to $206.7 million, surpassing the $201.3 million expectation, while net loss significantly narrowed to $25.2 million, reflecting improvements in business fundamentals.
- Market Reaction: Despite the positive earnings report, TLRY shares fell 1.5% in early Thursday trading, highlighting investor concerns regarding increasing regulatory restrictions on cannabis products in the U.S.
- Analyst Sentiment: While Alliance Global lowered its price target on TLRY to $7, the overall analyst outlook remains cautious, with 7 out of 10 analysts rating the stock as 'Hold', indicating a divergence in views on future growth potential.
See More
Tilray Brands Reports Record Q3 Revenue Driven by International Growth and Strategic Acquisitions
- Record Revenue: Tilray achieved net revenue of $206.7 million in Q3 FY2026, reflecting strong growth in international markets, which is expected to drive further growth in the future.
- International Market Growth: International cannabis sales reached $24.1 million, marking a 73% year-over-year increase, indicating Tilray's successful global positioning, particularly with its distribution network expanding to over 16,000 pharmacies in Germany, enhancing market penetration.
- Strategic Acquisitions and Partnerships: Tilray acquired BrewDog for approximately EUR 40 million, expected to elevate its global craft beverage platform to around $500 million, while also entering a strategic licensing partnership with Carlsberg set to launch in January 2027, further strengthening its beverage business.
- Profitability and Outlook: The company reaffirmed its fiscal 2026 adjusted EBITDA guidance range of $62 million to $72 million, and despite facing price pressures and rising aluminum costs, management remains optimistic about future profitability.
See More
Tilray Brands Reports Record Q3 Revenue of $206.7 Million
- Significant Revenue Growth: Tilray Brands Inc (NASDAQ:TLRY) achieved a record third-quarter revenue of $206.7 million, marking an 11% year-over-year increase, demonstrating strong performance in international markets, particularly with a 73% rise in international cannabis revenue and a 43% growth in Germany, laying a solid foundation for future expansion.
- Cost Savings Impact: The successful completion of Project 420 resulted in $33 million in annualized cost savings, improving the underlying cost structure of the beverage business, which enhances the company's profitability in a highly competitive market.
- Strategic Acquisition Boost: The acquisition of BrewDog positions Tilray as a $1.2 billion global revenue company, significantly enhancing its long-term growth profile, indicating its commitment to expanding in the global beverage market.
- Strong Financial Position: Tilray maintains a robust financial position with $265 million in cash, restricted cash, and marketable securities, providing flexibility for future growth investments, despite facing integration and regulatory challenges in international markets.
See More
Rythm and Green Thumb Amend Licensing Agreement for Long-Term Revenue
- Agreement Revision: Rythm amended its trademark and recipe licensing agreement with Green Thumb, allowing the latter to continue using Rythm's brand portfolio, including incredibles and Beboe, ensuring sustained market competitiveness.
- Fixed Annual Fee: Under the new terms, effective April 1, 2026, Green Thumb will pay Rythm a fixed annual cash fee of $70 million, with annual increases tied to inflation at twice the Consumer Price Index (CPI), providing Rythm with a stable long-term revenue stream.
- Stock Price Surge: Rythm's shares surged nearly 45% on Wednesday, marking the largest intraday gain of 2026 and breaching the 100-day moving average for the first time since December 18, 2025, indicating strong market confidence in its future growth.
- Market Sentiment Shift: Retail sentiment for RYM shifted from 'neutral' to 'extremely bullish', reflecting positive reactions to the new agreement, particularly regarding the anticipated boost in Rythm's gross margins from the royalty fees.
See More
Tilray Reports 19% Revenue Growth in Q3, Driven by International Sales Surge
- Surge in International Sales: Tilray's Q3 revenue climbed 19% to $206.7 million, driven by a remarkable 73% increase in international sales to $64.8 million, demonstrating strong demand in global markets and solidifying its position in the international cannabis sector.
- Significant Loss Reduction: The company's net loss narrowed dramatically from $793.5 million a year ago to $25.2 million, with loss per share improving to $0.24, although it fell short of the consensus estimate of $0.14, reflecting progress in cost control and operational efficiency.
- EBITDA Outlook Reaffirmed: Tilray reaffirmed its FY2026 EBITDA outlook between $62 million and $72 million, indicating confidence in future profitability, despite a 24% decline in beverage revenue to $42.6 million, with management remaining optimistic about international expansion.
- Investor Sentiment Shift: Following the strong earnings report, Tilray's shares jumped 4% on Wednesday, while retail investor sentiment on Stocktwits shifted from 'neutral' to 'extremely bullish', indicating market recognition of the company's growth potential.
See More
